Tonix Pharmaceuticals stock halted ahead of FDA approval news
LONDON - Renishaw plc (LSE:LON:RSW), a global provider of manufacturing technologies, analytical instruments and medical devices, announced Wednesday the appointment of Camille Deer as a Non-Executive Director effective September 1, 2025.
Deer, who is the granddaughter of company co-founder John Deer, will join the board after previously serving as an Observer. She brings experience in intellectual property, innovation pipeline and risk management from appointments outside Renishaw’s core business interests. Deer holds an MA and MPhil in History from the University of Cambridge.
Sir David Grant, Interim Non-Executive Chair, stated in the press release that Deer "is an excellent addition to the strength of our Board" and expressed confidence that "her appointment will prove to be invaluable in helping to guide the strategic direction of the business."
The appointment represents "continued commitment of the founding families to the future of Renishaw," according to Grant.
The company also noted it continues to search for a permanent Non-Executive Chair and an additional Independent (LON:IOG) Non-Executive Director to join the Board.
Renishaw confirmed there are no disclosures required regarding Deer’s appointment under UK Listing Rule 6.4.8R.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.